Finding the best dose of a malaria vaccine for school children
Part of Infections clinical trials.
This trial tests different doses of the R21/Matrix-M malaria vaccine in children who have already received four doses in a previous study. The goal is to find the most effective dose for ongoing protection against malaria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child received four doses of the R21/Matrix-M malaria vaccine in a previous study in Nanoro, Burkina Faso.
- You (parent or guardian) must sign a consent form confirming you understand and agree to the trial.
- Your child lives permanently in the study area and plans to stay there for the whole trial.
- Your child does not have severe allergies to any part of the malaria vaccine or to past vaccines.
- Your child does not have a serious health condition in major organs, severe anemia, or malnutrition needing hospital care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new long-acting malaria prevention injection (MMV371) in healthy adults and adolescents in Rwanda. Researchers will monitor how safe it is and how your body processes it over 24 weeks.
This study tests an experimental malaria vaccine (CVD 36000) in healthy volunteers aged 18–50. Researchers will give you the vaccine and later expose you to malaria parasites in a controlled setting to see if the vaccine protects you. This helps develop a safer vaccine for people in malaria-prone countries.
This study looks at how well the R21/Matrix-M malaria vaccine works in real-life settings for children under 5. If your child is eligible for the vaccine and has a fever, they may be able to join and help us understand the vaccine's impact.
This trial tests a new combination of experimental malaria vaccines to see if they are safe and help protect against malaria. It includes both adults and young children in malaria-affected areas.
This study looks at how well the R21/Matrix-M malaria vaccine works and how safe it is in children who received it. It compares children who got malaria (or died) to healthy children who also got the vaccine.
This trial tests if adding a malaria vaccine to seasonal preventive medicines helps protect young children better from malaria. It is for healthy children living in certain areas of Burkina Faso and Mali.
Hear when a new Malaria (Plasmodium Falciparum) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.